Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition

Recruiting now · Phase 3

Conditions studied: Parenteral Nutrition

In brief

A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 versus NTCB-C in patients who require parenteral nutrition

Key facts

Study ID

NCT06625957

Run by

Yuhan Corporation

People needed

60

Starts

2024-12-04

Expected to finish

2025-07-18

Last updated by the study team

2025-01-07

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Those who are 19 years old or older at the screening visit
• Patients are expected to require PN for more than 3 days
• Patients who voluntarily signed the consent form

You may not qualify if…

• Patients are expected difficult to survive more than 3 days
• Patients BMI is over 30 kg/m2
• Patients having hypersensitivity to any peanut-, fish-, soy-, egg protein, or investigational drug
• Patients with difficult central venous line
• Patients judged to be unsuitable for this trial by investigators

Where it is running

• National Cancer Center — Gyeonggi-do, Goyang-si, South Korea (enrolling)
• Chonnam National University Hwasun Hospital — Jeollanam-do, Hwasun-gun, South Korea (enrolling)
• Jeonbuk National University Hospital — Jeollabuk-do, Jeonju-si, South Korea (enrolling)
• Severance Hospital — Seoul, Seodaemun-gu, South Korea (enrolling)
• Seoul National University Bundang — Gyeonggi-do, Seongnam-si, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.